BLACR

Bellevue Life Sciences Acquisition Corp. Rights
BLACR

Overview Fund Activity
Delisted

BLACR was delisted on the 14th of February, 2025.

Back to rankings

14 hedge funds and large institutions have $479K invested in Bellevue Life Sciences Acquisition Corp. Rights in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
14
Holders Change
+14
Holders Change %
–
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
HCM
1
Highbridge Capital Management
New York
$104K
2
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$64.8K
3
BFM
3
Boothbay Fund Management
New York
$51.3K
4
SCM
4
Saba Capital Management
New York
$41.3K
5
PC
5
Periscope Capital
Ontario, Canada
$39.2K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
HCM
1
Highbridge Capital Management
New York
$104K 576,469 +576,469 New
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$64.8K 360,000 +360,000 New
BFM
3
Boothbay Fund Management
New York
$51.3K 311,040 +311,040 New
SCM
4
Saba Capital Management
New York
$41.3K 250,000 +250,000 New
PC
5
Periscope Capital
Ontario, Canada
$39.2K 233,000 +233,000 New
OCM
6
Oaktree Capital Management
California
$28.9K 175,000 +175,000 New
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$27K 150,000 +150,000 New
SOA
8
Sea Otter Advisors
Florida
$26.1K 144,900 +144,900 New
CAC
9
Cowen and Company
New York
$22.5K 125,100 +125,100 New
WAM
10
Wolverine Asset Management
Illinois
$21.9K 121,585 +121,585 New
AA
11
AQR Arbitrage
Connecticut
$18K 100,000 +100,000 New
CS
12
Clear Street
New York
$16.1K 89,648 +89,648 New
MTCM
13
Mint Tower Capital Management
Netherlands
$14K 75,000 +75,000 New
BI
14
Bulldog Investors
New Jersey
$3.55K 23,664 +23,664 New